MedTrace Logo

Pathways to Improved Adolescent Mental Health in Conflict Affected Families

NCT05763719 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3024

Last updated 2026-04-20

No results posted yet for this study

Summary

The study combined a youth-friendly economic empowerment program (Rabbits for Resilience (RFR) with a gender equality couple curriculum program (HIKA) to advance knowledge on the combined and synergistic impact of structural interventions and pathways with families for improved adolescent mental health in resource-poor communities. The investigators' multidisciplinary team will conduct a randomized controlled trial with three arms (RFR only, HIKA only, RFR + HIKA) with young adolescents ages 10-14 years and the adolescents' mothers and fathers living in 1080 rural households in 30 villages in two rural conflict-affected territories of South Kivu province of Eastern Democratic Republic of Congo (DRC)

Conditions

  • Mental Health Issue
  • Gender Equality

Interventions

BEHAVIORAL

Rabbits for Resilience (RFR) + HIKA

Economic empowerment program using animal husbandry for young adolescents and healthy relationship program for parents/couples in same household

BEHAVIORAL

Rabbits for Resilience (RFR) only

Economic empowerment program using animal husbandry with young adolescents

BEHAVIORAL

HIKA Healthy Relationship Program

Healthy relationship program for parents/couples

Sponsors & Collaborators

  • PAIDEK/Promotion de la Famille Paysanne (PFP)

    collaborator UNKNOWN

  • The Prevention Collaborative

    collaborator UNKNOWN

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Nancy Glass, PhD · Johns Hopkins University School of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2026-07-01
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05763719 on ClinicalTrials.gov